No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 – 90
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
700 (estimated)
Sponsor
Laplace Interventional, Inc · Industry
Who this trial is looking for
This trial is looking for people with severe tricuspid regurgitation who still have symptoms despite treatment. Participants will be treated with a new device and will need to follow up after the procedure.
Are You a Good Fit for This Trial?
You may be able to join if
I am between 18 and 90 years old.
I have severe tricuspid regurgitation.
I have symptoms despite treatment for at least 30 days.
I am considered suitable for the device by my heart team.
I agree to follow all study requirements.
I am anatomically suitable for the Laplace device.
You may not be able to join if
My life expectancy is less than 12 months.
I need surgery within 30 days after the study procedure.
I have severe kidney issues.
I have used illegal drugs in the last 5 years.
I have had a stroke within the last 90 days.
I am pregnant or planning to be pregnant in the next 12 months.
I am involved in another similar study.
I am not suitable for the Laplace device.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
The objective of this clinical study is to assess the safety and efficacy of the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System for the treatment of symptomatic subjects with at least severe tricuspid regurgitation (TR).
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* 18 - 90 years of age at the time of the study procedure.
* Symptomatic TR despite being adequately treated with OMT by the Local Heart Team for at least 30 days prior to the time of study consent.
* Severe, massive or torrential tricuspid regurgitation determined by qualifying…
Inclusion Criteria:
* 18 - 90 years of age at the time of the study procedure.
* Symptomatic TR despite being adequately treated with OMT by the Local Heart Team for at least 30 days prior to the time of study consent.
* Severe, massive or torrential tricuspid regurgitation determined by qualifying echocardiogram using the 5-grade classification.
* Candidate felt suitable for transcatheter tricuspid valve replacement as determined by the local Heart Team and confirmed by the patient selection committee.
* Subject has provided informed consent and agrees to return for all required post-procedure follow-up visits.
* Anatomically suitable for the Laplace TTVR system.
Exclusion Criteria:
* Estimated life expectancy of less than 12 months.
* Need for emergent, urgent or planned surgery or intervention within 30 days following the study procedure. Planned or scheduled cardiac surgery within next 12 months.
* Severe renal insufficiency defined as eGFR \<25 mL/min or requiring chronic renal replacement therapy at the time of screening committee review.
* Current history (within last 5 years) of illicit drug use.
* Stroke or other major cerebrovascular event within 90-days prior to index procedure.
* Current or planned pregnancy within next 12 months for women of childbearing potential.
* Participation in another pre-market investigational device study or investigational drug study for a cardiac related drug.
* Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements. Any patient considered to be vulnerable.
* Anatomically unsuitable for the Laplace TTVR System
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.